|
|
Exchange: |
Over The Counter |
Security
Type: |
N/A |
Shares
Out: |
19,300,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$57.98 - $57.98 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Larose Jeffrey |
Chief Scientific Officer |
|
2012-12-21 |
4 |
AS |
$81.69 |
$133,493 |
D/D |
(1,627) |
25,738 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2012-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
27,365 |
|
- |
|
Yocher Robert E |
SVP, Regulatory & Quality |
|
2012-12-21 |
4 |
AS |
$81.69 |
$34,950 |
D/D |
(426) |
2,014 |
|
- |
|
Yocher Robert E |
SVP, Regulatory & Quality |
|
2012-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
2,440 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2012-12-21 |
4 |
AS |
$81.69 |
$43,647 |
D/D |
(532) |
1,443 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2012-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,975 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2012-12-21 |
4 |
AS |
$81.69 |
$314,140 |
D/D |
(3,829) |
70,977 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2012-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
74,806 |
|
- |
|
Farrell Lauren |
VP, Finance |
|
2012-12-21 |
4 |
AS |
$81.68 |
$33,225 |
D/D |
(405) |
2,028 |
|
- |
|
Farrell Lauren |
VP, Finance |
|
2012-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
2,433 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2012-12-21 |
4 |
AS |
$81.69 |
$52,425 |
D/D |
(639) |
3,853 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2012-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
4,492 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2012-12-20 |
4 |
AS |
$82.09 |
$43,672 |
D/D |
(532) |
5,735 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2012-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
6,267 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2012-12-20 |
4 |
AS |
$82.09 |
$85,538 |
D/D |
(1,042) |
22,990 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2012-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
24,032 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2012-12-20 |
4 |
AS |
$82.09 |
$44,082 |
D/D |
(537) |
725 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2012-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,262 |
1,262 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2012-12-20 |
4 |
AS |
$82.09 |
$196,031 |
D/D |
(2,388) |
65,806 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2012-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,612 |
68,194 |
|
- |
|
Farrell Lauren |
VP, Finance |
|
2012-12-20 |
4 |
AS |
$82.08 |
$19,945 |
D/D |
(243) |
1,183 |
|
- |
|
Farrell Lauren |
VP, Finance |
|
2012-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
1,426 |
|
- |
|
Harrison Seth Loring |
Director |
|
2012-12-14 |
4 |
S |
$81.01 |
$6,150,531 |
I/I |
(75,922) |
8,000 |
|
- |
|
Harrison Seth Loring |
Director |
|
2012-12-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,000 |
9,000 |
|
- |
|
Harrison Seth Loring |
Director |
|
2012-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
45,951 |
|
- |
|
776 Records found
|
|
Page 15 of 32 |
|
|